Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Intranasal Vycavert in Recreational Opioid Users
NCT01759446Phase 2Completed
- Sponsor
- Acura Pharmaceuticals, Inc.
- Start
- Feb 2013
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vycavert in pain, sponsored by Acura Pharmaceuticals, Inc.. Started Feb 2013; status: completed.
02
Drugs
Vycavert
03
Conditions
pain
Beyond the preview
Go deeper on NCT01759446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759446.